Company research
NORTECH SYSTEMS INC
CIK 722313Updated Sep 24, 2026
SecurityNSYS · NASDAQ · equity
NSYS price & chart
Loading TradingView…
NASDAQ:NSYS on TradingView ↗About the company
Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.
In the news
Nortech Systems Incorporated to Report Second Quarter 2026 Financial Results and Hold a Conference Call on August 12, 2026 ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
S-8 filing
SD filing
Submission of Matters to a Vote of Security Holders
Items 5.07
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 71,919,000Source | 72,435,000Source | 75,127,000Source | 69,540,000Source |
| Property, Plant and Equipment, NetUSD | 5,203,000Source | 6,232,000Source | 6,513,000Source | 6,408,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,655,000Source | 916,000Source | 960,000Source | 1,027,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 16,998,000Source | 14,875,000Source | 19,279,000Source | 15,975,000Source |
| Inventory, NetUSD | 20,695,000Source | 21,638,000Source | 21,660,000Source | 22,438,000Source |
| Assets, CurrentUSD | 56,150,000Source | 55,315,000Source | 58,793,000Source | 54,860,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,618,000Source | 4,094,000Source | 1,698,000Source | 1,334,000Source |
| Operating Lease, Right-of-Use AssetUSD | 7,016,000Source | 8,139,000Source | 6,917,000Source | 7,850,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 37,372,000Source | 38,430,000Source | 39,783,000Source | 41,460,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 250,000Source | 250,000Source | 250,000Source | 250,000Source |
| Common Stock, Value, IssuedUSD | 28,000Source | 28,000Source | 27,000Source | 27,000Source |
| Additional Paid in CapitalUSD | 17,855,000Source | 17,329,000Source | 16,929,000Source | 16,347,000Source |
| Retained Earnings (Accumulated Deficit)USD | 17,123,000Source | 17,375,000Source | 18,670,000Source | 11,826,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -709,000Source | -977,000Source | -532,000Source | -370,000Source |
| Stockholders' Equity Attributable to ParentUSD | 34,547,000Source | 34,005,000Source | 35,344,000Source | 28,080,000Source |
| Liabilities and EquityUSD | 71,919,000Source | 72,435,000Source | 75,127,000Source | 69,540,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 29,844,000Source | 21,428,000Source | 26,582,000Source | 26,398,000Source |
| Operating Lease, Liability, CurrentUSD | 1,332,000Source | 1,175,000Source | 1,033,000Source | 1,155,000Source |
| Accounts Payable, CurrentUSD | 12,809,000Source | 11,582,000Source | 15,924,000Source | 14,792,000Source |
| Operating Lease, Liability, NoncurrentUSD | 6,476,000Source | 7,773,000Source | 6,763,000Source | 7,549,000Source |
| Other Liabilities, NoncurrentUSD | 426,000Source | 284,000Source | 414,000Source | 95,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 503,000Source | 461,000Source | 423,000Source | 334,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,951,000Source | -4,405,000Source | 3,432,000Source | 1,746,000Source |
| Increase (Decrease) in InventoriesUSD | -485,000Source | 400,000Source | -716,000Source | 2,985,000Source |
| Increase (Decrease) in Accounts PayableUSD | 1,346,000Source | -3,956,000Source | 483,000Source | 2,216,000Source |
| Deferred Income Tax Expense (Benefit)USD | -558,000Source | -12,000Source | -2,362,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 2,743,000Source | -2,250,000Source | 1,769,000Source | 5,402,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -157,000Source | -1,263,000Source | -1,284,000Source | -2,426,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 661,000Source | 1,270,000Source | 1,284,000Source | 2,370,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,867,000Source | 2,765,000Source | -1,281,000Source | -2,667,000Source |
| Repayments of Long-term DebtUSD | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 739,000Source | -759,000Source | -806,000Source | 256,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 916,000Source | 1,675,000Source | 2,481,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 925,000Source | 764,000Source | 503,000Source | 476,000Source |
| Income Taxes Paid, NetUSD | 751,000Source | 473,000Source | 1,751,000Source | 237,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 20,000Source | -11,000Source | -10,000Source | -53,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 18,000Source | 89,000Source | 159,000Source | 150,000Source |
| Amortization of Intangible AssetsUSD | 18,000Source | 89,000Source | 159,000Source | 150,000Source |
| DepreciationUSD | 1,270,000Source | 1,649,000Source | 1,891,000Source | 1,768,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 120,000Source | 137,000Source | 54,000Source | 42,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | 0Source | 15,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | 23,000Source | 0Source | 15,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 10,790,000Source | 11,709,000Source | 12,354,000Source | 11,425,000Source |
| Income Tax Expense (Benefit)USD | 263,000Source | 356,000Source | -1,408,000Source | 1,467,000Source |
| InterestExpenseNonoperatingUSD | 964,000Source | 744,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -252,000Source | -1,295,000Source | 6,874,000Source | 2,010,000Source |
| Nonoperating Income (Expense)USD | — | — | -487,000Source | -411,000Source |
| Operating ExpensesUSD | 17,031,000Source | 16,917,000Source | 17,151,000Source | 16,592,000Source |
| Proceeds from Stock Options ExercisedUSD | 23,000Source | 38,000Source | 159,000Source | 51,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 118,365,000Source | 128,133,000Source | 139,332,000Source | 134,123,000Source |
| Cost of RevenueUSD | 100,359,000Source | 111,411,000Source | 116,228,000Source | 113,643,000Source |
| Operating Income (Loss)USD | 975,000Source | -195,000Source | 5,953,000Source | 3,888,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 11,000Source | -939,000Source | 5,466,000Source | 3,477,000Source |
| Income Tax Expense (Benefit)USD | 263,000Source | 356,000Source | -1,408,000Source | 1,467,000Source |
| Net Income (Loss) Attributable to ParentUSD | -252,000Source | -1,295,000Source | 6,874,000Source | 2,010,000Source |
| Earnings Per Share, BasicUSD per share | -0.09Source | -0.47Source | 2.53Source | 0.75Source |
| Earnings Per Share, DilutedUSD per share | -0.09Source | -0.47Source | 2.38Source | 0.7Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,776,680Source | 2,755,041Source | 2,722,135Source | 2,685,378Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,776,680Source | 2,755,041Source | 2,885,879Source | 2,891,285Source |
| Interest Expense (non-operating)USD | 964,000Source | 744,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 18,000Source | 89,000Source | 159,000Source | 150,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 120,000Source | 137,000Source | 54,000Source | 42,000Source |
| General and Administrative ExpenseUSD | 10,790,000Source | 11,709,000Source | 12,354,000Source | 11,425,000Source |
| Gross ProfitUSD | 18,006,000Source | 16,722,000Source | 23,104,000Source | 20,480,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | 3,307,000Source | 990,000Source |
| Interest ExpenseUSD | — | — | 487,000Source | 411,000Source |
| Nonoperating Income (Expense)USD | — | — | -487,000Source | -411,000Source |
| Operating ExpensesUSD | 17,031,000Source | 16,917,000Source | 17,151,000Source | 16,592,000Source |
| Preferred Stock, Dividends Per Share, DeclaredUSD per share | 0Source | 0Source | 0Source | 0Source |
| Research and Development ExpenseUSD | 1,172,000Source | 1,191,000Source | 1,199,000Source | 1,463,000Source |
| Selling ExpenseUSD | 4,803,000Source | 3,446,000Source | 3,598,000Source | 3,719,000Source |
Filing attachments
ex99-1.htm · 8-K · 2026-08-12
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nortech Systems Reports Second Quarter Results MINNEAPOLIS - August 12, 2026 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the second quarter ended June 30, 2026. 2026 Q2 Highlight…
Read attachment ↗ex99-1.htm · 8-K · 2026-05-13
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nortech Systems Reports First Quarter Results MINNEAPOLIS - May 13, 2026 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the first quarter ended March 31, 2026. 2026 Q1 Highlights: …
Read attachment ↗ex99-1.htm · 8-K · 2026-03-26
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nortech Systems Reports Fourth Quarter Results MINNEAPOLIS - March 26, 2026 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the fourth quarter ended December 31, 2025. 2025 Q4 Highl…
Read attachment ↗ex99-1.htm · 8-K · 2026-01-06
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 Nortech Systems Names Andrew Walko Senior Vice President of Global Operations MINNEAPOLIS, January 6, 2026 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, announced today that Andrew Walko has been named Senior Vi…
Read attachment ↗ex99-1.htm · 8-K · 2025-11-13
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nortech Systems Reports Third Quarter Results MINNEAPOLIS - November 13, 2025 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the third quarter ended September 30, 2025. 2025 Q3 Hig…
Read attachment ↗ex99-1.htm · 8-K · 2025-08-07
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nortech Systems Reports Second Quarter Results MINNEAPOLIS - August 7, 2025 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial and aerospace & defense markets, reported financial results for the second quarter ended June 30, 2025. 2025 Q2 Highlights…
Read attachment ↗